This inventor holds 1 USPTO granted patent. Top assignee: Merz Pharma Gmbh & Co Kgaa. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Harry Frank Abst: Innovator in Gynoid Lipodystrophy Treatment
Introduction
Harry Frank Abst is a notable inventor based in Oberursel, Germany. He has made significant contributions to the field of medical treatments, particularly in addressing gynoid lipodystrophy. His innovative approach combines advanced materials with effective compounds to tackle this condition.
Latest Patents
Harry Frank Abst holds a patent for the treatment of gynoid lipodystrophy. The patent focuses on the use of calcium (hydroxy)phosphate particles in conjunction with compounds that reduce local subcutaneous fat. This innovative treatment offers new hope for individuals affected by this condition.
Career Highlights
Abst is associated with Merz Pharma GmbH & Co. KGaA, a company known for its commitment to developing effective medical solutions. His work at Merz Pharma has allowed him to explore and implement groundbreaking treatments in the field of aesthetic medicine.
Collaborations
Some of his notable coworkers include Sabine Otto and Rainer Pooth. Their collaboration has contributed to the advancement of research and development in the treatments offered by Merz Pharma.
Conclusion
Harry Frank Abst's contributions to the treatment of gynoid lipodystrophy highlight his innovative spirit and dedication to improving patient outcomes. His work continues to inspire advancements in medical treatments.